Back to Search
Start Over
Difference in Neutropenia due to Administration Schedule of TAS-102.
- Source :
-
Case Reports in Oncology . Jan-Apr2017, Vol. 10 Issue 1, p226-229. 4p. - Publication Year :
- 2017
-
Abstract
- TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no known effective prevention method. Furthermore, the administration method of TAS-102 is complicated. We reported that neutropenia could be avoided by changing to a simple administration method of TAS-102. [ABSTRACT FROM AUTHOR]
- Subjects :
- *NEUTROPENIA
*COLON cancer
Subjects
Details
- Language :
- English
- ISSN :
- 16626575
- Volume :
- 10
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Case Reports in Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 122473503
- Full Text :
- https://doi.org/10.1159/000460242